Business

Gennex Laboratories Limited Press Release Mar 26 2025

Notice is hereby given that in pursuance of SEBI (PIT) Regulations, 2015 and Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the Securities of the Company shall remain closed from April 01, 2025 till 48 hours after the Public announcement through Board of Directors in their Meeting held for announcing the audited Financial Results for the Quarter and Year ended on March 31, 2025 along with other matters for which Trading Window is required to be closed.The Board Meeting date to approve the audited financial results of the Company for the quarter and year ending on March 31, 2025 will be informed in due course.All Promoters/designated/connected persons are advised not to trade in the securities of the Company either directly or indirectly during the aforesaid period of Closure of Trading Window.We request you to take the above information on record and acknowledge receipt of the same.

articleGennex Laboratories LimitedMarch 26, 20255/company/gennex-laboratories-limited/news/gennex-laboratories-limited-press-release-mar-26-2025
Gennex Laboratories Limited Press Release Mar 26 2025

About this update from Gennex Laboratories Limited

[{"type":"text","content":" Notice is hereby given that in pursuance of SEBI (PIT) Regulations, 2015 and Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the Securities of the Company shall remain closed from April 01, 2025 till 48 hours after the Public announcement through Board of Directors in their Meeting held for announcing the audited Financial Results for the Quarter and Year ended on March 31, 2025 along with other matters for which Trading Window is required to be closed.The Board Meeting date to approve the audited financial results of the Company for the quarter and year ending on March 31, 2025 will be informed in due course.All Promoters/designated/connected persons are advised not to trade in the securities of the Company either directly or indirectly during the aforesaid period of Closure of Trading Window.We request you to take the above information on record and acknowledge receipt of the same.View Attachment","length":1130,"tagName":"div"}]

More updates from Gennex Laboratories Limited